BioSpace News Archive

Terumo Blood and Cell Technologies (Terumo BCT) announces U.S. Food and Drug Administration (FDA) clearance of the Reveos Automated Whole Blood Processing System, the first whole blood automation device available in the U.S. that processes whole blood into platelets and other components in a single centrifugation cycle.

Enzymit , a specialty biochemical company developing cell-free enzymatic manufacturing technology, today announced its success in synthetically producing hyaluronic acid (HA) for use in a range of cosmetic, aesthetic, and therapeutic applications.

Outlook Therapeutics, Inc. today announced that Russell Trenary, President and Chief Executive Officer of Outlook Therapeutics will participate in a fireside chat at the BTIG Virtual Biotechnology Conference 2023 on Monday, August 7, 2023 at 1:00 PM ET.

Jaguar Health today announced the activation by the U.S. Food and Drug Administration (FDA) of a physician-requested Investigational New Drug (IND) application to evaluate crofelemer for treatment of uncontrolled diarrhea in a patient with short bowel syndrome (SBS).

Quansys Biosciences and The Michael J. Fox Foundation for Parkinson’s Research (MJFF), a non-profit organization dedicated to finding a cure for Parkinson’s disease (PD), today announced a strategic partnership to accelerate the pace of research into PD.

Cytovale ® Announces Commercial Launch of IntelliSep ® Sepsis Test, the First-of-its-Kind Diagnostic Tool for Emergency Departments.

CYduct Diagnostics an emerging force in women’s breast health would like to recognize the immeasurable impact that Dr. Susan Love, a visionary leader in defining solutions for breast disease had on our company.

Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a publicly-traded clinical-stage oncology company, today announced that it will present posters on its gamma secretase inhibitors AL102 and AL101 at the European Society for Molecular Oncology (ESMO) Congress 2023 , to be held in Madrid, Spain 20-24 October 2023.

On World Lung Cancer Day, Ocean Biomedical, Inc. is sharing details of its multi-pronged Lung Cancer Program built on novel immunotherapy discoveries by Scientific Co-founder Dr. Jack A. Elias.

Aspargo Laboratories, Inc. announced that it has submitted an Investigational New Drug application, which has been accepted for review, to the U.S. Food and Drug Administration for ASP-001 in the treatment of erectile dysfunction.